Assessment of the Impact of Early Treatment for Anorexia Nervosa in a Day Hospital on Food Symptomatology, the Outcome of Young Patients, and the Family Experience
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 164 people, planned
- Started
- 19 Feb 2024
- Expected to end
- Apr 2032
- Type of study
- Observational, 3 groups
- Treatments tested
- Day Hospital Treatment
- Multidisciplinary follow-up "as usual" within the service
- Conduct semi-structured qualitative interviews
- Record updated
- 29 January 2026
Who can take part
- Age
- 12 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adolescents in the age range of 12-18 years and their parents,
- First-time consultation at the MDA for anorexia nervosa (according to DSM-5) evolving for less than 12 months,
- Adolescents with clinical characteristics suitable for DH care
Who cannot take part
- Patients who have been followed by an eating disorder specialist in the past 12 months (at the MDA or elsewhere) or previously hospitalized for anorexia nervosa,
- Patients who have undergone family therapy in the past,
- Patients with a major psychiatric comorbidity or a metabolic condition interfering with eating or its regulation,
- Patients with BMI less than 13 kg/m2 for those under 14 years old, or less than 14 kg/m2 for those over 14 years old at the initial assessment,
- Parents and/or children who do not speak French or cannot read or write,
- Patients and families in a crisis situation requiring immediate hospitalization
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
During the management of chronic illnesses, the day hospital (DH) serves as a brief and effective alternative to traditional hospitalization, offering access to multidisciplinary care. Indeed, patients can benefit from a range of therapeutic tools provided by a multidisciplinary care team while remaining in their living environment. Numerous structures exist for the management of eating disorders, but primarily for severe cases, often following hospitalization, before transitioning to outpatient care. There is no alternative for the initial management of these patients.
Read full original descriptionShow less
The DH for the evaluation and early intervention in recent forms of anorexia nervosa at Maison de Solenn serves as a rapid entry point to specialized care. It allows for a thorough assessment and sustained management of eating disorders. Our hypothesis is that a multidisciplinary, intensive, and early intervention for patients with anorexia nervosa and their families in a day hospital would improve the short, medium, and long-term prognosis of the disease compared to conventional multidisciplinary outpatient care. It would also enhance the family's experience of this pathology and their coping skills.
The 3 groups in the trial
- Day hospital patient
Acceptance of the DH program (DH group): scheduling of 10 to 12 sessions over 12 weeks during a program session, followed by a reassessment at the end of the program. Outpatient follow-up thereafter.
Treatment: Day Hospital Treatment
- Outpatient
Refusal or inability to participate in the DH program: multidisciplinary follow-up "as usual" within the service (outpatient group).
Treatment: Multidisciplinary follow-up "as usual" within the service
- Parents
Treatment: Conduct semi-structured qualitative interviews
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 29 January 2026